Lisinopril And Hydrochlorothiazide Tablet
Product Images NDC 42708-150

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Lisinopril And Hydrochlorothiazide (NDC 42708-150). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Qpharma, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Figure 1 (3a53f18e Af9b 4932 8300 B3521e87528d 01)

Figure 1 (3a53f18e Af9b 4932 8300 B3521e87528d 01)
FDA Label Image

Figure 2 (3a53f18e Af9b 4932 8300 B3521e87528d 02)

Figure 2 (3a53f18e Af9b 4932 8300 B3521e87528d 02)
FDA Label Image

Label (42708 150 30)

Label (42708 150 30)
This appears to be a medication prescription label for Lisinopril and Hydrochlorothiazide tablets. It indicates the dosage and frequency of medication intake, along with instructions to take the tablets for a specified number of days.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.